Dr. Reddy’s Laboratories Ltd ADR annual free cash flow for fiscal TTM was ₹15.1 billion, a decrease of 52.8% from ₹32.1 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | 2011-03-31 | 2010-03-31 | 2009-03-31 | 2008-03-31 | 2007-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ₹15.1B | ₹32.1B | ₹12.0B | ₹18.0B | ₹40.0B | ₹9.1B | ₹23.1B | ₹23.7B | ₹21.2B | ₹7.0B | (₹19.5B) | ₹26.4B | ₹9.7B | ₹8.8B | ₹6.0B | ₹7.6B | (₹3.6B) | ₹8.9B | (₹256M) | (₹647M) | ₹7.1B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | (₹4.6B) | ₹10.7B | ₹3.6B | ₹5.4B | ₹4.5B | ₹10.8B | (₹2.2B) | ₹1.4B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More RDY metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All RDY financial statements → Interactive RDY charts →
About TickerBase · Data methodology & sources · Privacy · Terms